DDrare: Database of Drug Development for Rare Diseases

Searched query = "Myelomeningocele", "Myeloschisis", "Myelocele", "Myelocystocele", "Syringomyelocele"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = Atosiban; Botulinum A toxin; Device: In Utero Endoscopic Correction of Myelomeningocele IDE - Laparotomy/Uterine Exteriorization Technique; Device: In Utero Endoscopic Correction of Myelomeningocele IDE - Percutaneous Technique; Device: Minimally invasive fetoscopic repair of MMC; Device: Omnidirectional accelerometer monitor (3x3 cm and 16 g, Actical®, Philips Respironics); MMC; MONITOR; Placental Mesenchymal Stem Cells; Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracellular matrix; Procedure: Fetal surgery for MMC repair; Procedure: endoscopic repair of myelomeningocele before 26 SA; SA; Terbutaline; Uterine

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03936322 (ClinicalTrials.gov)	May 7, 2019	1/5/2019	Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study	Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study	Spina Bifida;Myelomeningocele;Neural Tube Defects	Device: Minimally invasive fetoscopic repair of MMC	Mayo Clinic	NULL	Enrolling by invitation	18 Years	N/A	Female	15	N/A	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT03936322
(ClinicalTrials.gov)

May 7, 2019

1/5/2019

Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study

Spina Bifida;Myelomeningocele;Neural Tube Defects

Device: Minimally invasive fetoscopic repair of MMC

Mayo Clinic

NULL

Enrolling by invitation

18 Years

N/A

Female

N/A

United States